ARCHIVES

Feds Set Guidelines For Pharma To Help Patients With Cost Of Drugs, While Steering Clear Of Anti-Kickback Law.

This article is from The Cancer Letter archive.

Vol. 32 No. 16 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

Higgins: VA Groups D Have Review; NCI: It’s Ad Hoc

December 2, 1977

Melanoma Vaccine Near Phase 3, Other Studies Discussed At ACS Seminar

April 13, 1990

UICC Grant Programs Available To Support International Activities

April 16, 1976

Study Finds That CTC Was Used Correctly In Medicare Patients

April 26, 2013

Government Offers Two Approval Standards For Assays: CLIA, FDA

January 30, 2009

NCI Begins Latin American Cancer Research Network

April 10, 2009